ARGA Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Buy
+163,426
New +$2.2M 0.06% 59
2021
Q4
Sell
-15,655
Closed -$204K 75
2021
Q3
$204K Hold
15,655
0.01% 71
2021
Q2
$230K Buy
+15,655
New +$219K 0.02% 69
2021
Q1
Sell
-15,655
Closed -$223K 75
2020
Q4
$223K Hold
15,655
0.01% 70
2020
Q3
$218K Sell
15,655
-30,470
-66% -$363K 0.02% 75
2020
Q2
$489K Hold
46,125
0.05% 69
2020
Q1
$372K Hold
46,125
0.06% 40
2019
Q4
$374K Hold
46,125
0.04% 46
2019
Q3
$350K Hold
46,125
0.04% 50
2019
Q2
$346K Hold
46,125
0.05% 45
2019
Q1
$374K Hold
46,125
0.06% 60
2018
Q4
$348K Hold
46,125
0.06% 63
2018
Q3
$319K Buy
46,125
+10,125
+28% +$67.7K 0.04% 55
2018
Q2
$232K Hold
36,000
0.03% 57
2018
Q1
$235K Hold
36,000
0.03% 63
2017
Q4
$270K Hold
36,000
0.03% 62
2017
Q3
$257K Hold
36,000
0.03% 63
2017
Q2
$303K Buy
+36,000
New +$293K 0.04% 65

Other funds holding RDY

ARGA Investment Management's RDY Position: Q2 2026 in Review

ARGA Investment Management opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 163,426 shares worth $2.37M. The stake represents 0.06% of the portfolio and ranks #59 among its holdings. This is a return to the name: ARGA Investment Management previously reported a position in RDY as recently as Q3 2021.

ARGA Investment Management first reported a position in RDY in Q2 2017 and has held it in 18 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • ARGA Investment Management held 163,426 shares of Dr. Reddy's Laboratories worth $2.37M as of Q2 2026.
  • Dr. Reddy's Laboratories was a new ARGA Investment Management position in Q2 2026.
  • Dr. Reddy's Laboratories made up 0.06% of ARGA Investment Management's portfolio in Q2 2026, its #59 holding.
  • ARGA Investment Management first reported a position in Dr. Reddy's Laboratories in Q2 2017 and has held it in 18 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on ARGA Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.